Page last updated: 2024-09-05

n-(3-pyridylmethyl)adriamycin and serine

n-(3-pyridylmethyl)adriamycin has been researched along with serine in 1 studies

Compound Research Comparison

Studies
(n-(3-pyridylmethyl)adriamycin)
Trials
(n-(3-pyridylmethyl)adriamycin)
Recent Studies (post-2010)
(n-(3-pyridylmethyl)adriamycin)
Studies
(serine)
Trials
(serine)
Recent Studies (post-2010) (serine)
1701323,9141156,084

Protein Interaction Comparison

ProteinTaxonomyn-(3-pyridylmethyl)adriamycin (IC50)serine (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.015
CholinesteraseEquus caballus (horse)0.016

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Charan Raja, MR; Harish, BS; Jayaraman, A; Kar Mahapatra, S; Kar, A; Srinivasan, S; Uppuluri, KB1

Other Studies

1 other study(ies) available for n-(3-pyridylmethyl)adriamycin and serine

ArticleYear
Oceanimonas sp. BPMS22-derived protein protease inhibitor induces anti-leishmanial immune responses through macrophage M2 to M1 repolarization.
    International immunopharmacology, 2022, Volume: 112

    Topics: Animals; Arginase; Cytokines; Immunity; Interleukin-12; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Nitric Oxide; Protease Inhibitors; RNA, Messenger; Serine; Tandem Mass Spectrometry; Trypsin

2022